Europe Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

Code: BMIRE00025498 | Pages: 132 | Industry: Pharmaceuticals | Date: Jul 2022 | Type: Regional

The travel vaccines market in Europe is expected to grow from US$ 995.47 million in 2021 to US$ 1,885.56 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

 

Hepatitis, HIV/AIDS, human papillomavirus (HPV), meningococcal disease, typhoid, and yellow fever are among the various chronic diseases detected across the region. Similarly, in 2021, the Centers for Disease Control and Prevention (CDC) launched the global immunization strategic framework 2021–2030. The framework provides a plan to vaccinate against vaccine-preventable diseases (VPDs), such as hepatitis A and B. Moreover, there are different vaccine routines for travelers proposed by WHO to prevent the spread of deadly infectious diseases. The vaccine routine includes routine vaccines for review before traveling, vaccines for certain destinations, and vaccines demanded by certain countries. In most cases, booster doses of routine vaccines are required if people have not followed the regular schedule. Such initiatives by WHO and CDC enhance the vaccine demand, thereby driving its market growth. On the other hand, the COVID–19 outbreak threatened public health. Various emergency actions were initiated during the pandemic, of which the COVAX initiative was aggressively enacted. Vaccination against COVID–19 was mandatory for people worldwide. Governments in every region mandated vaccines for people traveling within and outside countries. The COVID-19 pandemic contributed significantly to travel vaccines. Thus, the factors mentioned above are driving the market growth.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe travel vaccines market. The Europe travel vaccines market is expected to grow at a good CAGR during the forecast period.     

 

Europe Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Europe Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

Europe Travel Vaccines Market Segmentation         

 

Europe travel vaccines market is segmented into product, application, and country. The Europe travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Europe travel vaccines market, by application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the Europe travel vaccines market is segmented into France, Germany, Italy, the UK, Russia, and the Rest of Europe.    

 

Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.    

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Travel Vaccines Market – By Product

1.3.2        Europe Travel Vaccines Market – By Application

1.3.3        Europe Travel Vaccines Market – By Country

2.           Europe Travel Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Travel Vaccines Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Travel Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Significant Rise in Travel and Tourism

5.1.2        Growing Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        High Cost of Travel Vaccines

5.3         Market Opportunities

5.3.1        Awareness Regarding Vaccines

5.4         Future Trends

5.4.1        Significant Demand for Vaccines

5.5         Impact Analysis

6.           Travel Vaccines Market – Europe Analysis

6.1         Europe Travel Vaccines Marker Revenue Forecast and Analysis

7.           Europe Travel Vaccines Market Analysis – By Product

7.1         Overview

7.2         Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3         Hepatitis A

7.3.1        Overview

7.3.2        Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Hepatitis B

7.4.1        Overview

7.4.2        Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Meningococcal Vaccines

7.5.1        Overview

7.5.2        Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.           Europe Travel Vaccines Market Analysis – By Application

8.1         Overview

8.2         Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3         Domestic Travel

8.3.1        Overview

8.3.2        Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Outbound Travel

8.4.1        Overview

8.4.2        Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Travel Vaccines Market – Country Analysis

9.1         Overview

9.1.1        Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1          UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1          UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2          UK: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3          UK: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2          Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1          Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2          Germany: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3          Germany: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3          France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1          France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2          France: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3          France: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.4          Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.1          Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.2          Italy: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.4.3          Italy: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.5          Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.1          Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.2          Spain: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.5.3          Spain: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.6          Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.1          Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.2          Rest of Europe: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.6.3          Rest of Europe: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10.        Travel Vaccines Market–Industry Landscape

10.1      Overview

10.2      Growth Strategies in the Travel Vaccines Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.4      Inorganic Developments

10.4.1     Overview

11.        Company Profiles

11.1      GlaxoSmithKline plc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Merck & Co., Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sanofi

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Novartis AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Pfizer Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Dynavax Technologies

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Emergent BioSolutions Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Abbott

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Valneva SE.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             UK: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             UK: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Germany: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Germany: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             France: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             France: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Italy: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Italy: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Spain: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Spain: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Rest of Europe: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Rest of Europe: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Europe Travel vaccines Market

 

 

LIST OF FIGURES

Figure 1.           Europe Travel Vaccines Market Segmentation

Figure 2.           Europe Travel Vaccines Market – By Country

Figure 3.           Europe Travel Vaccines Market Overview

Figure 4.           Europe Outbound Segment Held Largest Share of Travel Vaccines Market by Product

Figure 5.           France to Show Significant Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Europe Travel Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10.        Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

Figure 11.        Europe Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 16.        Europe Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 19.        Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)

Figure 20.        UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 21.        Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 24.        Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 25.        Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 26.        Growth Strategies in the Travel Vaccines Market, (%)

  1. Abbott
  2. Dynavax Technologies
  3. Emergent BioSolutions Inc.
  4. GlaxoSmithKline plc
  5. Merck & Co., Inc.
  6. Novartis AG
  7. Pfizer Inc.
  8. Sanofi
  9. Valneva SE.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000